Literature DB >> 9329409

Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome.

S S Kaufman1, C A Loseke, J V Lupo, R J Young, N D Murray, L W Pinch, J A Vanderhoof.   

Abstract

OBJECTIVES: Massive intestinal resection results in short bowel syndrome and necessitates prolonged parenteral feeding. The purpose of this work was to assess the impact of late complications of short bowel syndrome, including intestinal bacterial overgrowth and enterocolitis, on the duration of parenteral nutrition (PN) in comparison with factors evident in the neonatal period.
METHODS: Retrospective chart review.
RESULTS: Of 49 children, 42 were weaned from parenteral nutrition after a treatment course of 17 +/- 14 months. In these 42, postresection small intestinal length equaled 81 +/- 65 cm; 45% had an ileocecal valve. Small intestinal length in the seven children who were PN dependent was 31 +/- 30 cm (p < 0.05); none had an ileocecal valve (p < 0.05). Bacterial overgrowth occurred in all seven PN-dependent children and in 23 of 42 children eventually weaned from PN (p < 0.05). When bacterial overgrowth was identified before weaning (n = 12), the duration pf PN was 28 +/- 17 months, but when bacterial overgrowth was first identified only after weaning (n = 11), the duration of PN was 16 +/- 13 months (p < 0.05). Small intestinal inflammation correlated with bacterial overgrowth (r = 0.69). Those children with severe enteritis identified before weaning remained on the PN regimen for 36 +/- 15 months, in comparison with 21 +/- 14 months in those with mild enteritis and 13 +/- 11 months in those without inflammation (p < 0.02).
CONCLUSIONS: Although the length of small intestine remaining after resection is the best immediate predictor of final success in terminating PN in children with short bowel syndrome, PN is prolonged by bacterial overgrowth and associated enteritis in those who will ultimately be weaned.

Entities:  

Mesh:

Year:  1997        PMID: 9329409     DOI: 10.1016/s0022-3476(97)80058-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  47 in total

1.  Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure.

Authors:  Y Kanamori; K Hashizume; M Sugiyama; M Morotomi; N Yuki
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

2.  T-cell dysfunction in a patient with short bowel syndrome: report of a case.

Authors:  K Kono; T Sekikawa; H Iizuka; F Ichihara; H Amemiya; T Ishikawa; Y Matsumoto
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses.

Authors:  Conrad R Cole; Juliana C Frem; Brian Schmotzer; Andrew T Gewirtz; Jonathan B Meddings; Benjamin D Gold; Thomas R Ziegler
Journal:  J Pediatr       Date:  2010-02-20       Impact factor: 4.406

4.  Multiple micronutrient deficiencies in a child with short bowel syndrome and normal somatic growth.

Authors:  Debora Duro; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-04       Impact factor: 2.839

5.  Necrotizing Enterocolitis and Central Line Associated Blood Stream Infection Are Predictors of Growth Outcomes in Infants with Short Bowel Syndrome.

Authors:  Bram P Raphael; Paul D Mitchell; Darryl Finkton; Hongyu Jiang; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr       Date:  2015-04-01       Impact factor: 4.406

6.  Small bowel resection induces long-term changes in the enteric microbiota of mice.

Authors:  J Sommovilla; Y Zhou; R C Sun; P M Choi; J Diaz-Miron; N Shaikh; E Sodergren; B B Warner; G M Weinstock; P I Tarr; B W Warner
Journal:  J Gastrointest Surg       Date:  2014-09-03       Impact factor: 3.452

Review 7.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

8.  Predictors of Enteral Autonomy in Children with Intestinal Failure: A Multicenter Cohort Study.

Authors:  Faraz A Khan; Robert H Squires; Heather J Litman; Jane Balint; Beth A Carter; Jeremy G Fisher; Simon P Horslen; Tom Jaksic; Samuel Kocoshis; J Andres Martinez; David Mercer; Susan Rhee; Jeffrey A Rudolph; Jason Soden; Debra Sudan; Riccardo A Superina; Daniel H Teitelbaum; Robert Venick; Paul W Wales; Christopher Duggan
Journal:  J Pediatr       Date:  2015-04-25       Impact factor: 4.406

9.  Variability of resting energy expenditure in infants and young children with intestinal failure-associated liver disease.

Authors:  Debora Duro; Paul D Mitchell; Nilesh M Mehta; Lori J Bechard; Yong-Ming Yu; Tom Jaksic; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-05       Impact factor: 2.839

10.  Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months.

Authors:  Conrad R Cole; Nellie I Hansen; Rosemary D Higgins; Thomas R Ziegler; Barbara J Stoll
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.